Back To Search Results

Pulmonary Function Tests and Thoracic Cage Abnormalities

Editor: Abdulghani Sankari Updated: 2/27/2024 11:01:40 PM

Summary / Explanation

The respiratory system is an essential component of the human body, responsible for maintaining oxygen levels and removing carbon dioxide.[1] Pulmonary function tests (PFTs) are a set of diagnostic tools used to diagnose and assess the functionality of the respiratory system. By combining these tests with the knowledge of thoracic cage abnormalities, healthcare professionals can gain valuable insights into pulmonary health and make informed treatment decisions with their patients.

Pulmonary Function Test Overview

PFTs encompass a range of tests designed to evaluate the performance of the lungs and the respiratory muscles. These tests are instrumental in diagnosing respiratory disorders, monitoring disease progression, and assessing treatment effectiveness. The primary PFTs include spirometry, lung volume measurements, and gas exchange studies.[2][3][4]

Spirometry

Spirometry is a fundamental PFT that measures the amount and speed of air an individual can inhale and exhale. This test is essential for diagnosing and monitoring patients with chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases. Common parameters obtained from spirometry include forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and the FEV1/FVC ratio. The results are then represented on a graph.[5][6][7][8]

Lung Volume Measurements

Two methods are used to measure lung volumes: body plethysmography and gas dilution (nitrogen washout and inert gas dilution).[9][10] These tests assess the total air the lungs can hold and how well air moves in and out of the lungs. Lung volume measurements include total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV). The diagnosis of restriction often involves the use of lung volumes. In obstructive lung disease cases, lung volumes are used to evaluate hyperinflation. Other clinical conditions cause changes in lung volumes as well.[11][12]

Gas Exchange Studies

Gas exchange studies evaluate how efficiently the lungs transfer oxygen to the bloodstream and remove carbon dioxide. Diffusing capacity for carbon monoxide (DLCO) is a common parameter measured in these studies. This test employs inhaled CO because of its strong attraction to hemoglobin, which is 200 to 250 times greater than oxygen. Reduced DLCO may suggest conditions such as pulmonary fibrosis or emphysema.[13] An association exists between DLCO and more severe respiratory symptom scores. As the DLCO worsens, this association is stronger, indicating that impaired gas exchange can significantly harm one's quality of life.[14]

Understanding Thoracic Cage Abnormalities

The thoracic cage, comprising the ribcage and sternum, serves as the structural foundation for the respiratory system. Abnormalities in the thoracic cage can alter respiratory mechanics and impact lung function.

Kyphosis and Scoliosis 

Kyphosis, an excessive outward curvature of the spine, and scoliosis, a lateral curvature, can affect the thoracic cage's shape.[15] These conditions may restrict lung expansion, reducing vital capacity and potentially leading to respiratory compromise. Improvements in PFTs and increases in lung volume were seen after deformity correction in patients with local kyphosis.[16]

Pectus Excavatum and Pectus Carinatum

Pectus excavatum is characterized by a sunken sternum, while pectus carinatum presents as a protruding chest.[17][18] Both conditions can impact lung function by altering the space for lung expansion. Individuals with these abnormalities may experience decreased lung volumes and compromised respiratory efficiency.

Thoracic Deformities and Chest Wall Rigidity

Certain congenital or acquired thoracic deformities, such as thoracic insufficiency syndrome, can limit chest wall expansion. Additionally, conditions causing chest wall rigidity, such as ankylosing spondylitis, can restrict lung movement, leading to decreased lung volumes.[19]

The Interplay Between PFTs and Thoracic Cage Abnormalities

Understanding the relationship between PFTs and thoracic cage abnormalities is crucial for comprehensive respiratory assessment. PFT results can often pinpoint the specific nature and severity of respiratory dysfunction, while thoracic cage abnormalities provide insights into the structural factors contributing to these issues.[6]

Diagnostic Value

PFTs help clinicians differentiate between obstructive and restrictive respiratory disorders. For example, conditions like asthma and COPD primarily exhibit obstructive patterns on spirometry, while restrictive lung diseases, including those associated with thoracic cage abnormalities, result in reduced lung volumes.

Treatment Planning

Identifying thoracic cage abnormalities through imaging studies, such as x-rays or CT scans, in conjunction with PFTs guides treatment planning. Surgical interventions, physical therapy, or respiratory exercises may be recommended based on the underlying structural issues affecting respiratory function.

Monitoring Progression

PFTs are crucial in monitoring disease progression and treatment effectiveness in individuals with thoracic cage abnormalities. Changes in lung function parameters over time can inform clinicians about the impact of interventions and guide adjustments to the treatment plan. Some lung diseases may also present with mixed lung capacities over time, elucidating long-term treatment strategies.

Integrating Assessments for Holistic Respiratory Care

Integrating PFTs and evaluating thoracic cage abnormalities are essential for a comprehensive understanding of respiratory health. By combining the functional insights provided by PFTs with an awareness of structural issues affecting the thoracic cage, healthcare professionals can tailor interventions to address each patient's unique needs. This holistic approach enhances diagnostic accuracy, guides treatment strategies, and ultimately improves the quality of care for individuals with respiratory disorders and thoracic cage abnormalities.[20][21]

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

References


[1]

Hurley JJ, Hensley JL. Physiology, Airway Resistance. StatPearls. 2024 Jan:():     [PubMed PMID: 31194340]


[2]

Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Culver B, Derom E, Hall GL, Hallstrand TS, Leuppi JD, MacIntyre N, McCormack M, Rosenfeld M, Swenson ER. ERS/ATS technical standard on interpretive strategies for routine lung function tests. The European respiratory journal. 2022 Jul:60(1):. pii: 2101499. doi: 10.1183/13993003.01499-2021. Epub 2022 Jul 13     [PubMed PMID: 34949706]


[3]

Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force. General considerations for lung function testing. The European respiratory journal. 2005 Jul:26(1):153-61     [PubMed PMID: 15994402]


[4]

Ponce MC, Sankari A, Sharma S. Pulmonary Function Tests. StatPearls. 2024 Jan:():     [PubMed PMID: 29493964]


[5]

Paine NJ, Joseph MF, Bacon SL, Julien CA, Cartier A, Ditto B, Favreau H, Lavoie KL. Association Between Depression, Lung Function, and Inflammatory Markers in Patients with Asthma and Occupational Asthma. Journal of occupational and environmental medicine. 2019 Jun:61(6):453-460. doi: 10.1097/JOM.0000000000001562. Epub     [PubMed PMID: 30855523]


[6]

Lamb K, Theodore D, Bhutta BS. Spirometry. StatPearls. 2024 Jan:():     [PubMed PMID: 32809361]


[7]

Hegewald MJ, Gallo HM, Wilson EL. Accuracy and Quality of Spirometry in Primary Care Offices. Annals of the American Thoracic Society. 2016 Dec:13(12):2119-2124     [PubMed PMID: 27598295]

Level 2 (mid-level) evidence

[8]

Firnhaber J. Performance and Interpretation of Office Spirometry. Primary care. 2021 Dec:48(4):645-654. doi: 10.1016/j.pop.2021.07.004. Epub 2021 Oct 7     [PubMed PMID: 34752275]


[9]

Lofrese JJ, Tupper C, Denault D, Lappin SL. Physiology, Residual Volume. StatPearls. 2024 Jan:():     [PubMed PMID: 29630222]


[10]

Olson JM, Warawa JM. Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis. Journal of visualized experiments : JoVE. 2023 Feb 24:(192):. doi: 10.3791/62722. Epub 2023 Feb 24     [PubMed PMID: 36912512]


[11]

Flesch JD, Dine CJ. Lung volumes: measurement, clinical use, and coding. Chest. 2012 Aug:142(2):506-510. doi: 10.1378/chest.11-2964. Epub     [PubMed PMID: 22871760]


[12]

Yoshimi K, Seyama K. [Spirometry and other pulmonary function tests for the screening and evaluation of patients with chronic obstructive pulmonary disease (COPD)]. Nihon rinsho. Japanese journal of clinical medicine. 2007 Apr:65(4):664-9     [PubMed PMID: 17419385]


[13]

Modi P, Cascella M. Diffusing Capacity Of The Lungs For Carbon Monoxide. StatPearls. 2024 Jan:():     [PubMed PMID: 32310609]


[14]

Byanova KL, Fitzpatrick J, Jan AK, McGing M, Hartman-Filson M, Farr CK, Zhang M, Gardner K, Branchini J, Kerruish R, Bhide S, Bates A, Hsieh J, Abelman R, Hunt PW, Wang RJ, Crothers KA, Huang L. Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection. PloS one. 2023:18(7):e0288803. doi: 10.1371/journal.pone.0288803. Epub 2023 Jul 18     [PubMed PMID: 37463173]


[15]

Issac S, M Das J. Kyphoscoliosis. StatPearls. 2024 Jan:():     [PubMed PMID: 32965854]


[16]

Lin S, Ma S, Zhou Z, Ge Z, Wang Y, Yang C, Huang Z, Cao K. Improvement of pulmonary function and reconstructed 3D lung volume after deformity correction for thoracic spinal posttubercular kyphosis: a multicenter study. Journal of neurosurgery. Spine. 2023 Jul 1:39(1):58-64. doi: 10.3171/2023.3.SPINE221382. Epub 2023 Apr 7     [PubMed PMID: 37029674]

Level 2 (mid-level) evidence

[17]

McHam B, Winkler L. Pectus Carinatum. StatPearls. 2024 Jan:():     [PubMed PMID: 31082165]


[18]

Sharma G, Carter YM. Pectus Excavatum. StatPearls. 2024 Jan:():     [PubMed PMID: 28613668]


[19]

Rea G, Sezen CB. Chest Wall Deformities. StatPearls. 2024 Jan:():     [PubMed PMID: 31971714]


[20]

Bokov P, Delclaux C. [Interpretation and use of routine pulmonary function tests: Spirometry, static lung volumes, lung diffusion, arterial blood gas, methacholine challenge test and 6-minute walk test]. La Revue de medecine interne. 2016 Feb:37(2):100-10. doi: 10.1016/j.revmed.2015.10.356. Epub 2015 Dec 3     [PubMed PMID: 26657268]


[21]

Townsend MC, Occupational and Environmental Lung Disorders Committee. Spirometry in the occupational health setting--2011 update. Journal of occupational and environmental medicine. 2011 May:53(5):569-84. doi: 10.1097/JOM.0b013e31821aa964. Epub     [PubMed PMID: 21555926]